Chemours Co Stock Analysis

Chemours Stock Analysis Notes

About 78.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 1.67. Chemours recorded a loss per share of 1.6. The entity last dividend was issued on the 23rd of February 2024. The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware. Chemours operates under Specialty Chemicals classification in the United States and is traded on New York Stock Exchange. It employs 6400 people. For more info on Chemours Co please contact Mark Vergnano at 302 773 1000 or go to https://www.chemours.com.

Chemours Investment Alerts

Chemours Upcoming and Recent Events

Chemours Largest EPS Surprises

View All Earnings Estimates

Chemours Thematic Classifications

Chemours Stock Institutional Investors

Note, although Chemours' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Chemours Market Capitalization

The company currently falls under 'Mid-Cap' category with a market capitalization of 3.86 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Chemours's market, we take the total number of its shares issued and multiply it by Chemours's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Chemours Profitablity

The company has Net Profit Margin (PM) of (0.04) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.07 %, which signifies that for every $100 of sales, it has a net operating income of $0.07.

Management Efficiency

Chemours has Return on Asset (ROA) of 0.0529 % which means that for every $100 of assets, it generated a profit of $0.0529. This is way below average. Likewise, it shows a return on total equity (ROE) of (0.2568) %, which implies that it produced no returns to current stockholders. Chemours' management efficiency ratios could be used to measure how well Chemours manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.03. The current year's Return On Capital Employed is expected to grow to -0.01. At present, Chemours' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 2.11, whereas Total Assets are forecasted to decline to about 7.5 B.

Technical Drivers

As of the 23rd of April, Chemours shows the mean deviation of 3.0, and Risk Adjusted Performance of 0.0112. Chemours technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down nineteen technical drivers for Chemours Co, which can be compared to its peers. Please confirm Chemours variance, maximum drawdown, and the relationship between the coefficient of variation and jensen alpha to decide if Chemours is priced correctly, providing market reflects its regular price of 26.43 per share. Given that Chemours has jensen alpha of (0.09), we suggest you to validate Chemours Co's prevailing market performance to make sure the company can sustain itself at a future point.

Chemours Price Movement Analysis

Chemours Insider Trading Activities

Chemours Outstanding Bonds

Chemours Predictive Daily Indicators

Chemours Corporate Filings

Chemours Forecast Models

Chemours' time-series forecasting models are one of many Chemours' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Chemours' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Chemours prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Chemours shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Chemours. By using and applying Chemours Stock analysis, traders can create a robust methodology for identifying Chemours entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Chemours analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Chemours analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Chemours Co stock analysis indicators help investors evaluate how Chemours stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Chemours shares will generate the highest return on investment. By understating and applying Chemours stock analysis, traders can identify Chemours position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.

Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.